- Home
- HELP vs PROK Comparison
HELP vs PROK Comparison
Compare HELP & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$7.76
HOLD
Current Price
$2.31
Company Overview
Basic Information| Metric | HELP | PROK |
|---|---|---|
| Founded | N/A | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 375.7M | 331.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HELP | PROK |
|---|---|---|
| Price | $7.76 | $2.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.40 |
| AVG Volume (30 Days) | 847.6K | ★ 1.1M |
| Earning Date | 02-13-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $744,000.00 |
| Revenue This Year | N/A | $956.51 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.81 | $0.46 |
| 52 Week High | $10.72 | $7.13 |
Technical Indicators
Market Signals| Indicator | HELP | PROK |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 49.22 |
| Support Level | N/A | $2.15 |
| Resistance Level | N/A | $2.37 |
| Average True Range (ATR) | 0.00 | 0.15 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 45.96 |
Price Performance
Historical Comparison HELP
PROK
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.